Xenglu Met 12.5/850mg Tablet 28s – Empagliflozin + Metformin XR Dual Therapy
Xenglu Met 12.5/850mg Tablet 28s – Empagliflozin + Metformin XR Dual Therapy
Xenglu Met 12.5/850mg Tablet 28s – Empagliflozin + Metformin XR Dual Therapy
Description
Xenglu Met 12.5/850mg Tablet 28s – Balanced Dual-Action Formula with Heart & Kidney Protection
Xenglu Met 12.5/850mg Tablet combines empagliflozin 12.5mg (SGLT2 inhibitor) with metformin extended-release 850mg in a single once-daily tablet. This mid-strength combination provides powerful glucose lowering through two complementary pathways while offering excellent stomach tolerance thanks to the extended-release metformin. Patients benefit from significant A1C reduction, modest weight loss, lower blood pressure, and clinically proven protection against heart failure and diabetic kidney disease progression. The 28-tablet pack delivers a convenient full month of treatment.
